SIRT6 and Glucose intolerance: While genetic, chronic SIRT6 inhibition in macrophages promotes inflammation and insulin resistance (20), pharmacological inhibition of SIRT6 ameliorates glucose intolerance during diet-induced obesity (DIO) (19).